Loading…
Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood
IL-10 producing regulatory type 1 (Tr1) cells represents a subpopulation of CD4+ regulatory cells able to prevent in vitro bystander T-cell proliferation and to inhibit a wide range of inflammatory diseases in mice. Our aim was to evaluate the frequency and function of joint specific Tr1 cells in th...
Saved in:
Published in: | International immunopharmacology 2011-08, Vol.11 (8), p.1074-1078 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c423t-50ea8cbe33b09ce442f187d682dc7a754ef247882bb2cced4939e9113bd9435b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c423t-50ea8cbe33b09ce442f187d682dc7a754ef247882bb2cced4939e9113bd9435b3 |
container_end_page | 1078 |
container_issue | 8 |
container_start_page | 1074 |
container_title | International immunopharmacology |
container_volume | 11 |
creator | Brun, Valérie Neveu, Virginie Pers, Yves Marie Fabre, Sylvie Quatannens, Brigitte Bastian, Hervé Clerget-Chossat, Nathalie Jorgensen, Christian Foussat, Arnaud |
description | IL-10 producing regulatory type 1 (Tr1) cells represents a subpopulation of CD4+ regulatory cells able to prevent in vitro bystander T-cell proliferation and to inhibit a wide range of inflammatory diseases in mice. Our aim was to evaluate the frequency and function of joint specific Tr1 cells in the peripheral blood of severe Rheumatoid Arthritis (RA) patients. The collagen II protein was chosen to isolate Tr1 cells specific for a joint antigen. We successfully isolated Tr1 clones from 9 out of 11 RA patients. We showed that cells from patients display the same phenotype and surface marker regulation as previously shown for human Tr1 cells, characterized by expression of markers of regulation (FoxP3, CD25) at the activated but not at the resting state. Importantly, cells from patients showed Tr1 cytokine secretion (IL-10 and IFN-γ) and immunosuppressive action on bystander T cell proliferation. Based on these results, we demonstrated that collagen II specific Tr1 cells can be isolated from the blood of severe refractory patients and that these cells are not altered in their phenotype and function. |
doi_str_mv | 10.1016/j.intimp.2011.03.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_883044229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1567576911001226</els_id><sourcerecordid>878029537</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-50ea8cbe33b09ce442f187d682dc7a754ef247882bb2cced4939e9113bd9435b3</originalsourceid><addsrcrecordid>eNqFkcuO1DAQRS0EYoaGP0DIG8Qqwa_EyQYJjXhEaonNsLYcu9LjlmM3tgPi73GrG9jBxlWLU-V76yL0kpKWEtq_PbYuFLeeWkYobQlvCaGP0C0d5NBQSbrHte962XSyH2_Qs5yPFZBE0KfohlFBeibJLfox5eh1cTHguOBlC-bca4_1VqKPh7hlbKL3-gChmSacT2Dc4gye9g0l-JSi3YwLB3yfKDbgPTY-Bsh4SXHF6QG2VZfoLNapPCRXXMazj9E-R08W7TO8uNYd-vrxw_3d52b_5dN0937fGMF4aToCejAzcD6T0YAQbKkGbT8wa6SWnYCFCTkMbJ6ZMWDFyEcYKeWzHQXvZr5Dby57q9JvG-SiVpfPOnWA6k0NAyd1Kxv_T8qBsLHjspLiQpoUc06wqFNyq04_FSXqnI06qks26pyNIlzV09exV9cPtnkF-2fodxgVeH0FdDbaL0kH4_JfTnBJeX136N2Fg3q47w6SysZBqPZdAlOUje7fSn4BxlSvoA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>878029537</pqid></control><display><type>article</type><title>Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood</title><source>Elsevier</source><creator>Brun, Valérie ; Neveu, Virginie ; Pers, Yves Marie ; Fabre, Sylvie ; Quatannens, Brigitte ; Bastian, Hervé ; Clerget-Chossat, Nathalie ; Jorgensen, Christian ; Foussat, Arnaud</creator><creatorcontrib>Brun, Valérie ; Neveu, Virginie ; Pers, Yves Marie ; Fabre, Sylvie ; Quatannens, Brigitte ; Bastian, Hervé ; Clerget-Chossat, Nathalie ; Jorgensen, Christian ; Foussat, Arnaud</creatorcontrib><description>IL-10 producing regulatory type 1 (Tr1) cells represents a subpopulation of CD4+ regulatory cells able to prevent in vitro bystander T-cell proliferation and to inhibit a wide range of inflammatory diseases in mice. Our aim was to evaluate the frequency and function of joint specific Tr1 cells in the peripheral blood of severe Rheumatoid Arthritis (RA) patients. The collagen II protein was chosen to isolate Tr1 cells specific for a joint antigen. We successfully isolated Tr1 clones from 9 out of 11 RA patients. We showed that cells from patients display the same phenotype and surface marker regulation as previously shown for human Tr1 cells, characterized by expression of markers of regulation (FoxP3, CD25) at the activated but not at the resting state. Importantly, cells from patients showed Tr1 cytokine secretion (IL-10 and IFN-γ) and immunosuppressive action on bystander T cell proliferation. Based on these results, we demonstrated that collagen II specific Tr1 cells can be isolated from the blood of severe refractory patients and that these cells are not altered in their phenotype and function.</description><identifier>ISSN: 1567-5769</identifier><identifier>EISSN: 1878-1705</identifier><identifier>DOI: 10.1016/j.intimp.2011.03.001</identifier><identifier>PMID: 21406270</identifier><language>eng</language><publisher>Kidlington: Elsevier B.V</publisher><subject>Aged ; Arthritis, Rheumatoid - blood ; Arthritis, Rheumatoid - immunology ; Biological and medical sciences ; CD4-Positive T-Lymphocytes - cytology ; CD4-Positive T-Lymphocytes - immunology ; Cell Growth Processes - physiology ; Clone Cells ; Collagen Type II - blood ; Collagen Type II - immunology ; Diseases of the osteoarticular system ; Female ; Forkhead Transcription Factors - metabolism ; Humans ; Immune Tolerance ; Immunotherapy ; Inflammatory joint diseases ; Interferon-gamma - immunology ; Interleukin-10 - biosynthesis ; Interleukin-10 - immunology ; Interleukin-2 Receptor alpha Subunit - metabolism ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Phenotype ; Regulatory Tr1 cells ; Rheumatoid arthritis ; T-Lymphocytes, Regulatory - cytology ; T-Lymphocytes, Regulatory - immunology</subject><ispartof>International immunopharmacology, 2011-08, Vol.11 (8), p.1074-1078</ispartof><rights>2011 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-50ea8cbe33b09ce442f187d682dc7a754ef247882bb2cced4939e9113bd9435b3</citedby><cites>FETCH-LOGICAL-c423t-50ea8cbe33b09ce442f187d682dc7a754ef247882bb2cced4939e9113bd9435b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24371324$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21406270$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brun, Valérie</creatorcontrib><creatorcontrib>Neveu, Virginie</creatorcontrib><creatorcontrib>Pers, Yves Marie</creatorcontrib><creatorcontrib>Fabre, Sylvie</creatorcontrib><creatorcontrib>Quatannens, Brigitte</creatorcontrib><creatorcontrib>Bastian, Hervé</creatorcontrib><creatorcontrib>Clerget-Chossat, Nathalie</creatorcontrib><creatorcontrib>Jorgensen, Christian</creatorcontrib><creatorcontrib>Foussat, Arnaud</creatorcontrib><title>Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood</title><title>International immunopharmacology</title><addtitle>Int Immunopharmacol</addtitle><description>IL-10 producing regulatory type 1 (Tr1) cells represents a subpopulation of CD4+ regulatory cells able to prevent in vitro bystander T-cell proliferation and to inhibit a wide range of inflammatory diseases in mice. Our aim was to evaluate the frequency and function of joint specific Tr1 cells in the peripheral blood of severe Rheumatoid Arthritis (RA) patients. The collagen II protein was chosen to isolate Tr1 cells specific for a joint antigen. We successfully isolated Tr1 clones from 9 out of 11 RA patients. We showed that cells from patients display the same phenotype and surface marker regulation as previously shown for human Tr1 cells, characterized by expression of markers of regulation (FoxP3, CD25) at the activated but not at the resting state. Importantly, cells from patients showed Tr1 cytokine secretion (IL-10 and IFN-γ) and immunosuppressive action on bystander T cell proliferation. Based on these results, we demonstrated that collagen II specific Tr1 cells can be isolated from the blood of severe refractory patients and that these cells are not altered in their phenotype and function.</description><subject>Aged</subject><subject>Arthritis, Rheumatoid - blood</subject><subject>Arthritis, Rheumatoid - immunology</subject><subject>Biological and medical sciences</subject><subject>CD4-Positive T-Lymphocytes - cytology</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Cell Growth Processes - physiology</subject><subject>Clone Cells</subject><subject>Collagen Type II - blood</subject><subject>Collagen Type II - immunology</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Forkhead Transcription Factors - metabolism</subject><subject>Humans</subject><subject>Immune Tolerance</subject><subject>Immunotherapy</subject><subject>Inflammatory joint diseases</subject><subject>Interferon-gamma - immunology</subject><subject>Interleukin-10 - biosynthesis</subject><subject>Interleukin-10 - immunology</subject><subject>Interleukin-2 Receptor alpha Subunit - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Regulatory Tr1 cells</subject><subject>Rheumatoid arthritis</subject><subject>T-Lymphocytes, Regulatory - cytology</subject><subject>T-Lymphocytes, Regulatory - immunology</subject><issn>1567-5769</issn><issn>1878-1705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkcuO1DAQRS0EYoaGP0DIG8Qqwa_EyQYJjXhEaonNsLYcu9LjlmM3tgPi73GrG9jBxlWLU-V76yL0kpKWEtq_PbYuFLeeWkYobQlvCaGP0C0d5NBQSbrHte962XSyH2_Qs5yPFZBE0KfohlFBeibJLfox5eh1cTHguOBlC-bca4_1VqKPh7hlbKL3-gChmSacT2Dc4gye9g0l-JSi3YwLB3yfKDbgPTY-Bsh4SXHF6QG2VZfoLNapPCRXXMazj9E-R08W7TO8uNYd-vrxw_3d52b_5dN0937fGMF4aToCejAzcD6T0YAQbKkGbT8wa6SWnYCFCTkMbJ6ZMWDFyEcYKeWzHQXvZr5Dby57q9JvG-SiVpfPOnWA6k0NAyd1Kxv_T8qBsLHjspLiQpoUc06wqFNyq04_FSXqnI06qks26pyNIlzV09exV9cPtnkF-2fodxgVeH0FdDbaL0kH4_JfTnBJeX136N2Fg3q47w6SysZBqPZdAlOUje7fSn4BxlSvoA</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>Brun, Valérie</creator><creator>Neveu, Virginie</creator><creator>Pers, Yves Marie</creator><creator>Fabre, Sylvie</creator><creator>Quatannens, Brigitte</creator><creator>Bastian, Hervé</creator><creator>Clerget-Chossat, Nathalie</creator><creator>Jorgensen, Christian</creator><creator>Foussat, Arnaud</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20110801</creationdate><title>Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood</title><author>Brun, Valérie ; Neveu, Virginie ; Pers, Yves Marie ; Fabre, Sylvie ; Quatannens, Brigitte ; Bastian, Hervé ; Clerget-Chossat, Nathalie ; Jorgensen, Christian ; Foussat, Arnaud</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-50ea8cbe33b09ce442f187d682dc7a754ef247882bb2cced4939e9113bd9435b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Arthritis, Rheumatoid - blood</topic><topic>Arthritis, Rheumatoid - immunology</topic><topic>Biological and medical sciences</topic><topic>CD4-Positive T-Lymphocytes - cytology</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Cell Growth Processes - physiology</topic><topic>Clone Cells</topic><topic>Collagen Type II - blood</topic><topic>Collagen Type II - immunology</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Forkhead Transcription Factors - metabolism</topic><topic>Humans</topic><topic>Immune Tolerance</topic><topic>Immunotherapy</topic><topic>Inflammatory joint diseases</topic><topic>Interferon-gamma - immunology</topic><topic>Interleukin-10 - biosynthesis</topic><topic>Interleukin-10 - immunology</topic><topic>Interleukin-2 Receptor alpha Subunit - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Regulatory Tr1 cells</topic><topic>Rheumatoid arthritis</topic><topic>T-Lymphocytes, Regulatory - cytology</topic><topic>T-Lymphocytes, Regulatory - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brun, Valérie</creatorcontrib><creatorcontrib>Neveu, Virginie</creatorcontrib><creatorcontrib>Pers, Yves Marie</creatorcontrib><creatorcontrib>Fabre, Sylvie</creatorcontrib><creatorcontrib>Quatannens, Brigitte</creatorcontrib><creatorcontrib>Bastian, Hervé</creatorcontrib><creatorcontrib>Clerget-Chossat, Nathalie</creatorcontrib><creatorcontrib>Jorgensen, Christian</creatorcontrib><creatorcontrib>Foussat, Arnaud</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>International immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brun, Valérie</au><au>Neveu, Virginie</au><au>Pers, Yves Marie</au><au>Fabre, Sylvie</au><au>Quatannens, Brigitte</au><au>Bastian, Hervé</au><au>Clerget-Chossat, Nathalie</au><au>Jorgensen, Christian</au><au>Foussat, Arnaud</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood</atitle><jtitle>International immunopharmacology</jtitle><addtitle>Int Immunopharmacol</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>11</volume><issue>8</issue><spage>1074</spage><epage>1078</epage><pages>1074-1078</pages><issn>1567-5769</issn><eissn>1878-1705</eissn><abstract>IL-10 producing regulatory type 1 (Tr1) cells represents a subpopulation of CD4+ regulatory cells able to prevent in vitro bystander T-cell proliferation and to inhibit a wide range of inflammatory diseases in mice. Our aim was to evaluate the frequency and function of joint specific Tr1 cells in the peripheral blood of severe Rheumatoid Arthritis (RA) patients. The collagen II protein was chosen to isolate Tr1 cells specific for a joint antigen. We successfully isolated Tr1 clones from 9 out of 11 RA patients. We showed that cells from patients display the same phenotype and surface marker regulation as previously shown for human Tr1 cells, characterized by expression of markers of regulation (FoxP3, CD25) at the activated but not at the resting state. Importantly, cells from patients showed Tr1 cytokine secretion (IL-10 and IFN-γ) and immunosuppressive action on bystander T cell proliferation. Based on these results, we demonstrated that collagen II specific Tr1 cells can be isolated from the blood of severe refractory patients and that these cells are not altered in their phenotype and function.</abstract><cop>Kidlington</cop><pub>Elsevier B.V</pub><pmid>21406270</pmid><doi>10.1016/j.intimp.2011.03.001</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1567-5769 |
ispartof | International immunopharmacology, 2011-08, Vol.11 (8), p.1074-1078 |
issn | 1567-5769 1878-1705 |
language | eng |
recordid | cdi_proquest_miscellaneous_883044229 |
source | Elsevier |
subjects | Aged Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - immunology Biological and medical sciences CD4-Positive T-Lymphocytes - cytology CD4-Positive T-Lymphocytes - immunology Cell Growth Processes - physiology Clone Cells Collagen Type II - blood Collagen Type II - immunology Diseases of the osteoarticular system Female Forkhead Transcription Factors - metabolism Humans Immune Tolerance Immunotherapy Inflammatory joint diseases Interferon-gamma - immunology Interleukin-10 - biosynthesis Interleukin-10 - immunology Interleukin-2 Receptor alpha Subunit - metabolism Male Medical sciences Pharmacology. Drug treatments Phenotype Regulatory Tr1 cells Rheumatoid arthritis T-Lymphocytes, Regulatory - cytology T-Lymphocytes, Regulatory - immunology |
title | Isolation of functional autologous collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A56%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isolation%20of%20functional%20autologous%20collagen-II%20specific%20IL-10%20producing%20Tr1%20cell%20clones%20from%20rheumatoid%20arthritis%20blood&rft.jtitle=International%20immunopharmacology&rft.au=Brun,%20Val%C3%A9rie&rft.date=2011-08-01&rft.volume=11&rft.issue=8&rft.spage=1074&rft.epage=1078&rft.pages=1074-1078&rft.issn=1567-5769&rft.eissn=1878-1705&rft_id=info:doi/10.1016/j.intimp.2011.03.001&rft_dat=%3Cproquest_cross%3E878029537%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c423t-50ea8cbe33b09ce442f187d682dc7a754ef247882bb2cced4939e9113bd9435b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=878029537&rft_id=info:pmid/21406270&rfr_iscdi=true |